Quick Takeaways
- Invus Public Equities, L.P. has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $404,662,025.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Invus Public Equities, L.P.
- Location
- New York, NY
- Summary
- The estimated net worth of Invus Public Equities, L.P. is at least $404,662,025 dollars as of 12 Dec 2024. Invus Public Equities, L.P. is the 10%+ Owner of Scholar Rock Holding Corp and owns shares of Scholar Rock Holding Corp (SRRK) stock worth about $385.26M. Invus Public Equities, L.P. is the 10%+ Owner of Omega Therapeutics, Inc. and owns shares of Omega Therapeutics, Inc. stock worth about $18.19M. Invus Public Equities, L.P. is the 10%+ Owner of GLYCOMIMETICS INC and owns shares of CRESCENT BIOPHARMA, INC. (CBIO) stock worth about $1.21M.
- Signature
- Invus Public Equities, L.P., By: Invus Public Equities Advisors, LLC, its General Partner, By: /s/ Raymond Debbane, President
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Invus Public Equities, L.P. and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Scholar Rock Holding Corp ($385,262,708).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Invus Public Equities, L.P.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | 10%+ Owner | $385,262,708 | 10 Dec 2024 | ||
| OMGA | Omega Therapeutics, Inc. | 10%+ Owner | $18,188,240 | 30 Jul 2021 | ||
| CBIO | GLYCOMIMETICS INC | 10%+ Owner | $1,211,077 | 07 Aug 2024 |
Insider Transactions Reported by Invus Public Equities, L.P.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.